MacroGenics
MGNX
#9393
Rank
ยฃ65.05 M
Marketcap
ยฃ1.03
Share price
-0.72%
Change (1 day)
-61.29%
Change (1 year)

Revenue for MacroGenics (MGNX)

Revenue in 2025 (TTM): ยฃ94.71 Million

According to MacroGenics's latest financial reports the company's current revenue (TTM ) is ยฃ94.58 Million. In 2024 the company made a revenue of ยฃ0.11 Billion an increase over the revenue in the year 2023 that were of ยฃ44.89 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for MacroGenics from 2013 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ94.71 M-19.87%
2024 ยฃ0.11 B163.31%
2023 ยฃ44.89 M-63.69%
2022 ยฃ0.12 B119.28%
2021 ยฃ56.38 M-21.38%
2020 ยฃ71.72 M51.64%
2019 ยฃ47.29 M2.38%
2018 ยฃ46.19 M-59.85%
2017 ยฃ0.11 B63.99%
2016 ยฃ70.16 M4.65%
2015 ยฃ67.05 M120.88%
2014 ยฃ30.35 M-11.77%
2013 ยฃ34.4 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Xencor
XNCR
ยฃ0.12 B 32.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ47.13 B 49,729.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ48.21 B 50,879.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ21.83 B 22,983.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ27.00 B 28,447.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ44.60 B 47,057.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ36.05 B 38,021.62%๐Ÿ‡บ๐Ÿ‡ธ USA